Tradipitant
Brand names: Nereus · Active ingredient: Tradipitant
In short: NEREUS is indicated for the prevention of vomiting induced by motion in adults.
What is Tradipitant used for?
NEREUS is indicated for the prevention of vomiting induced by motion in adults.
Tradipitant dosage
The recommended dosage of NEREUS is 85 mg or 170 mg as a single oral dose. Use the lowest effective dose. The safety of NEREUS for the prevention of vomiting induced by motion in adults for more than 90 doses has not been established in clinical trials .
Administer NEREUS orally approximately 60 minutes before an event expected to cause vomiting induced by motion.
The maximum dosage in a 24-hour period is a single dose of 85 mg or 170 mg.
Administer NEREUS on an empty stomach, at least 1 hour prior to or 2 hours after a full meal .
How to take Tradipitant — instructions & advice from the label
Effects on the Ability to Drive or Operate Machinery
Advise patients NEREUS may cause somnolence and/or fatigue and impair the mental and/or physical abilities required for driving a motor vehicle or operating heavy machinery and to avoid concomitant use of other drugs with NEREUS as it may increase this effect . If concomitant use is unavoidable, warn patients against driving and other activities requiring complete mental alertness .
Administration Information
Advise the patient:
Take NEREUS approximately 60 minutes before an event expected to cause vomiting induced by motion.
The maximum dosage in a 24-hour period is a single dose of 85 or 170 mg.
Administer NEREUS on an empty stomach, at least 1 hour prior to or 2 hours after a full meal .
Lactation
Advise breastfeeding women using NEREUS to monitor infants for somnolence and to seek medical care if they notice this sign .
Distributed By:
Vanda Pharmaceuticals Inc. Washington, D.C. 20037 USA
Warnings & precautions
Do not take this medicine if: None.
In placebo-controlled clinical trials, somnolence (6%, 12%) and fatigue (6%, 8%) were adverse reactions reported in subjects who took a single dose of 85 mg or 170 mg NEREUS, respectively . NEREUS may impair the mental and/or physical abilities required for driving a motor vehicle or operating heavy machinery. Concomitant use of other drugs that cause central nervous system depression and strong CYP3A4 inhibitors may increase this effect . If concomitant use is unavoidable, warn patients against driving and other activities requiring complete mental alertness.
Tradipitant side effects
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The safety of a single 85 mg or 170 mg dose of NEREUS was evaluated in adult subjects with a history of motion sickness in two randomized, double-blind, placebo-controlled trials, Study 1 and Study 2 . Additional safety data for the 170 mg dose of NEREUS were obtained from a randomized, double-blind, placebo-controlled trial, Study 3 (NCT03772340).
Adverse reactions reported in at least 5% of subjects treated with a single NEREUS 85 mg or 170 mg dose and at a higher frequency than subjects who received placebo, are shown in Table 1.
aReported in at least 5% of subjects and at a higher frequency than placebo.
bNEREUS was administered as a single 85 mg dose approximately 60 minutes prior to a boat trip and without food.
cNEREUS was administered as a single 170 mg dose approximately 60 minutes prior to a boat trip and without food. …
Drug interactions
Strong CYP3A4 Inhibitors
Tradipitant is a CYP3A4 substrate. Strong CYP3A4 inhibitors may increase tradipitant exposure, which may increase the risk of adverse reactions to NEREUS.
About this medicine
NEREUS (tradipitant) is a substance P/neurokinin-1 (NK-1) receptor antagonist designated by the chemical name, as {2-[1-(3,5-Bistrifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone, with molecular formula C28H16ClF6N5O, and molecular weight 587.9. The chemical structure for tradipitant is:
Tradipitant is a white to off-white crystalline powder. It is practically insoluble in water, soluble in methanol, and slightly soluble in isopropyl alcohol and simulated gastric fluid.
NEREUS is supplied as white opaque body capsules with “VANDA 85mg” printed in white on the black opaque cap for oral administration, each containing 85 mg tradipitant. Inactive ingredients are croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, and sodium lauryl sulfate. The capsule contains FD&C blue No 1, FD&C red No 40, and FD&C yellow No 6, gelatin, and titanium dioxide.
How it works: Tradipitant is a selective, high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 1a021ebd-16ac-4354-b4b2-1c3950c091e5. Read the full official label on DailyMed.
Related medicines
Omeprazole Pantoprazole Fluoxetine Amoxicillin Famotidine Ondansetron Esomeprazole Docusate